BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22879588)

  • 1. The biology of small leucine-rich proteoglycans in bone pathophysiology.
    Nikitovic D; Aggelidakis J; Young MF; Iozzo RV; Karamanos NK; Tzanakakis GN
    J Biol Chem; 2012 Oct; 287(41):33926-33. PubMed ID: 22879588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles for small leucine-rich proteoglycans in bone formation.
    Waddington RJ; Roberts HC; Sugars RV; Schönherr E
    Eur Cell Mater; 2003 Oct; 6():12-21; discussion 21. PubMed ID: 14562268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycosylation profile of osteoadherin alters during endochondral bone formation.
    Sugars RV; Olsson ML; Marchner S; Hultenby K; Wendel M
    Bone; 2013 Apr; 53(2):459-67. PubMed ID: 23337037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity.
    Zamurovic N; Cappellen D; Rohner D; Susa M
    J Biol Chem; 2004 Sep; 279(36):37704-15. PubMed ID: 15178686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biglycan knockout mice: new models for musculoskeletal diseases.
    Young MF; Bi Y; Ameye L; Chen XD
    Glycoconj J; 2002; 19(4-5):257-62. PubMed ID: 12975603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction.
    Schaefer L; Iozzo RV
    J Biol Chem; 2008 Aug; 283(31):21305-9. PubMed ID: 18463092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA.
    Tscheudschilsuren G; Bosserhoff AK; Schlegel J; Vollmer D; Anton A; Alt V; Schnettler R; Brandt J; Proetzel G
    Exp Cell Res; 2006 Jan; 312(1):63-72. PubMed ID: 16256983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small leucine-rich proteoglycans in kidney disease.
    Schaefer L
    J Am Soc Nephrol; 2011 Jul; 22(7):1200-7. PubMed ID: 21719787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of small leucine-rich proteoglycans in osteoarthritis pathogenesis.
    Ni GX; Li Z; Zhou YZ
    Osteoarthritis Cartilage; 2014 Jul; 22(7):896-903. PubMed ID: 24795272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of osteoadherin (OSAD) by TGF-beta1 and BMP-2.
    Rehn AP; Chalk AM; Wendel M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1057-64. PubMed ID: 16970923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site.
    Monfort J; Tardif G; Reboul P; Mineau F; Roughley P; Pelletier JP; Martel-Pelletier J
    Arthritis Res Ther; 2006; 8(1):R26. PubMed ID: 16507124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
    Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
    Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small leucine rich repeat proteoglycans (SLRPs) in the human sclera: identification of abundant levels of PRELP.
    Johnson JM; Young TL; Rada JA
    Mol Vis; 2006 Sep; 12():1057-66. PubMed ID: 17093390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling.
    Qiao B; Padilla SR; Benya PD
    J Biol Chem; 2005 Apr; 280(17):17562-71. PubMed ID: 15743758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system.
    Niedźwiedzki T; Filipowska J
    J Mol Endocrinol; 2015 Oct; 55(2):R23-36. PubMed ID: 26307562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of SLRP-proteoglycans in osteosarcoma pathogenesis.
    Nikitovic D; Berdiaki K; Chalkiadaki G; Karamanos N; Tzanakakis G
    Connect Tissue Res; 2008; 49(3):235-8. PubMed ID: 18661350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans.
    McEwan PA; Scott PG; Bishop PN; Bella J
    J Struct Biol; 2006 Aug; 155(2):294-305. PubMed ID: 16884925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.
    Bi Y; Stuelten CH; Kilts T; Wadhwa S; Iozzo RV; Robey PG; Chen XD; Young MF
    J Biol Chem; 2005 Aug; 280(34):30481-9. PubMed ID: 15964849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis.
    Erlacher L; McCartney J; Piek E; ten Dijke P; Yanagishita M; Oppermann H; Luyten FP
    J Bone Miner Res; 1998 Mar; 13(3):383-92. PubMed ID: 9525338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar bone turnover and periodontal ligament width are controlled by Wnt.
    Lim WH; Liu B; Mah SJ; Yin X; Helms JA
    J Periodontol; 2015 Feb; 86(2):319-26. PubMed ID: 25345341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.